Page 15 - David Ricks News Today

-The U.S. Food and Drug Administration said on Thursday its preliminary review did not find evidence that weight-loss drugs such as Novo Nordisks Wegovy were tied to suicidal thoughts.... -January 11, 2024 at 12:35 pm EST - MarketScreener

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisks...

Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound.

Eli Lilly CEO David Ricks, speaking to the slow and steady progress that brought tirzepitide to the world, says the Indianapolis pharma is now ready to open…

Amid mounting evidence of obesity drugs' long-term health benefits, thorny questions persist about their value to employers

BioPharma

In addition, the Ricks Family Foundation says it will match up to an additional $2.5 million in donations from individuals, foundations and corporations.

Several big pharma companies are rushing into the GLP-1 obesity space, which currently has two market leaders. How they plan to take some of that market share will be the story of the drug class for 2024.

I'm out at the JPMorgan Health Care Conference in San Francisco and lots is going on for health-related Club companies.

LillyDirect offers disease management resources, tailored support and direct home delivery of select medications through third-party pharmacy dispensing services.